Kelly Tran

Title: Kelly Tran: Innovator in Hematopoietic Disorder Treatments

Introduction

Kelly Tran is a prominent inventor based in East Palo Alto, CA. She has made significant contributions to the field of medicine, particularly in the treatment of hematopoietic disorders. Her innovative work has led to the development of therapies that can potentially improve patient outcomes in serious conditions.

Latest Patents

Kelly Tran holds a patent for "Combination therapies for treating myelodysplastic syndromes and acute myeloid leukemia." This patent includes methods, kits, and compositions that utilize an anti-CD47 agent, such as an antibody, in conjunction with a hypomethylating agent like azacitidine. This combination aims to provide effective treatment options for patients suffering from these hematopoietic disorders. She has 1 patent to her name.

Career Highlights

Kelly Tran is currently employed at Forty Seven, Inc., a company dedicated to advancing cancer therapies. Her role at the company allows her to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.

Collaborations

Throughout her career, Kelly has worked alongside notable colleagues, including Yinuo Cao and Mark P Chao. These collaborations have fostered an environment of innovation and shared knowledge, further enhancing the impact of their work in the medical field.

Conclusion

Kelly Tran is a remarkable inventor whose work in hematopoietic disorder treatments showcases her dedication to improving patient care. Her innovative approaches and collaborations with esteemed colleagues position her as a key figure in the ongoing fight against serious medical conditions.